- Home
- RDY vs PRGS Comparison
RDY vs PRGS Comparison
Compare RDY & PRGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDY
- PRGS
- Stock Information
- Founded
- RDY 1984
- PRGS 1981
- Country
- RDY India
- PRGS United States
- Employees
- RDY N/A
- PRGS N/A
- Industry
- RDY Biotechnology: Pharmaceutical Preparations
- PRGS Computer Software: Prepackaged Software
- Sector
- RDY Health Care
- PRGS Technology
- Exchange
- RDY Nasdaq
- PRGS Nasdaq
- Market Cap
- RDY 2.1B
- PRGS 2.4B
- IPO Year
- RDY N/A
- PRGS 1991
- Fundamental
- Price
- RDY $14.49
- PRGS $47.65
- Analyst Decision
- RDY Strong Buy
- PRGS Buy
- Analyst Count
- RDY 2
- PRGS 7
- Target Price
- RDY $16.95
- PRGS $72.86
- AVG Volume (30 Days)
- RDY 1.4M
- PRGS 1.4M
- Earning Date
- RDY 07-28-2025
- PRGS 06-30-2025
- Dividend Yield
- RDY 0.56%
- PRGS 0.37%
- EPS Growth
- RDY 1.47
- PRGS N/A
- EPS
- RDY 0.79
- PRGS 1.30
- Revenue
- RDY $3,809,801,863.00
- PRGS $869,017,000.00
- Revenue This Year
- RDY $10.24
- PRGS $31.04
- Revenue Next Year
- RDY N/A
- PRGS $1.70
- P/E Ratio
- RDY $18.37
- PRGS $36.50
- Revenue Growth
- RDY 16.61
- PRGS 22.10
- 52 Week Low
- RDY $12.26
- PRGS $47.46
- 52 Week High
- RDY $16.89
- PRGS $70.56
- Technical
- Relative Strength Index (RSI)
- RDY 43.00
- PRGS 24.78
- Support Level
- RDY $14.51
- PRGS $47.52
- Resistance Level
- RDY $14.70
- PRGS $49.00
- Average True Range (ATR)
- RDY 0.16
- PRGS 1.94
- MACD
- RDY -0.06
- PRGS -0.66
- Stochastic Oscillator
- RDY 23.42
- PRGS 6.06
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About PRGS Progress Software Corporation (DE)
Progress Software Corporation provides software operate in one operating segment: software products for the development, deployment, and management of responsible, AI-powered applications and digital experiences. Following are products: Chef, Corticon, Data Direct, Developer Tools, Flowmon, Kemp LoadMaster, MarkLogic, MOVEit, OpenEdge, Semaphore, ShareFile, Sitefinity, WhatsUp Gold. Geographical regions include United States, Canada, EMEA, Latin America, and Asia Pacific.